Photo of Mike Kelly
R United States House · District 16 · Pennsylvania On the 2026 ballot

Rep. Mike Kelly

Compare
Total votes
2,837
all sessions
Attendance
95%
150 missed
Near the chamber average
With party
95%
of cast votes
Higher than 86% of chamber peers
Bipartisan score
3%
crosses aisle rarely
Lower than 87% of chamber peers
Sponsored
1,026
bills & resolutions
Near the chamber average
Committees
3
assignments
1,026 bills and resolutions

Sponsored bills

Total
1,026
Primary
86
Co-sponsor
940
This page
1,026
matching current filters
Co-sponsor HR 6466
In committee · United States House · Co-sponsor
Forced Abortion Prevention and Accountability Act

Maddy summaryHR 6466, the Forced Abortion Prevention and Accountability Act, prohibits non-consensual administration of abortion drugs (like mifepristone or misoprostol) to pregnant women without their informed consent. It criminalizes this act with penalties up to 25 years in prison and allows victims to sue for triple damages, psychological/physical injury compensation, and attorney fees. The bill directly affects pregnant women who might face coerced procedures and medical providers or others who administer such drugs without consent. Key provisions include criminal penalties for the act itself, enhanced penalties for serious injury or death, and a civil remedy framework for victims seeking compensation.

In committee Dec 4, 2025 1 co-sponsor
Primary HR 6446
In committee · United States House · Lead sponsor
To modify the procedures for investigating claims of evasion of antidumping and countervailing duty orders.

Maddy summaryHR 6446 modifies how U.S. customs officials investigate suspected evasion of antidumping and countervailing duty orders on imported goods. It allows the Commissioner to start an investigation independently if they have evidence of evasion, not just when a complaint is filed. Additionally, importers found to have evaded duties must pay all owed customs fees before they can challenge the decision in court. These changes streamline enforcement and clarify the process for addressing duty evasion.

In committee Dec 4, 2025 0 co-sponsors
Co-sponsor HR 6439
In committee · United States House · Co-sponsor
Border Patrol Supervisors Retention Act

Maddy summaryThis bill amends federal pay rules to expand higher overtime pay rates for U.S. Border Patrol supervisors. It changes the eligibility from only GS-12 agents to include all supervisors classified from GS-12 through GS-15. The key provision modifies Section 5550(h) of Title 5, U.S. Code, to apply the higher overtime pay rate to these higher-grade supervisory positions. The bill aims to improve retention for experienced Border Patrol supervisors by increasing their overtime compensation.

In committee Dec 4, 2025 1 co-sponsor
Co-sponsor HR 5284
Passed · United States House · Co-sponsor
Claiming Age Clarity Act

Maddy summaryThe Claiming Age Clarity Act (HR 5284) requires the Social Security Administration to update its official terminology by January 1, 2027. It directs the replacement of specific terms: "early eligibility age" becomes "minimum monthly benefit age," "full retirement age" and "normal retirement age" become "standard monthly benefit age," and "delayed retirement credit" is eliminated, with "maximum monthly benefit age" used instead of age 70 references. This change applies to all Social Security Administration rules, regulations, guidance, and materials, both online and in print, affecting how the agency communicates retirement benefit rules to the public.

Passed Dec 2, 2025 1 co-sponsor
Co-sponsor HR 1262
Passed · United States House · Co-sponsor
Mikaela Naylon Give Kids a Chance Act

Give Kids a Chance Act of 2025 This bill expands the Food and Drug Administration’s (FDA’s) authority with respect to research on rare pediatric diseases, including by permitting the FDA to take enforcement action against drug sponsors that fail to satisfy pediatric study requirements and by reauthorizing programs that support pediatric research.  Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations to permit research on new drugs in combination with active ingredients that have already been approved, provided certain conditions are met; permits the FDA to take enforcement action against drug sponsors that fail to comply with pediatric study requirements, if such sponsors demonstrated a lack of due diligence in satisfying the requirement; renews the FDA’s authority to award priority review vouchers to sponsors of new products intended to treat rare pediatric diseases through September 30, 2029; and reauthorizes through FY2027 certain funding for the National Institutes of Health to support priority pediatric research.  The bill also provides statutory authority for the FDA’s interpretation of the orphan drug exclusivity period. The bill specifies, consistent with FDA regulations, that the seven-year market exclusivity period for drugs for rare diseases or conditions (i.e., orphan drugs) prohibits the approval of the same drug for the same approved use or indication with respect to the disease or condition. (In Catalyst Pharmaceuticals, Inc. v. Becerra , a court rejected the FDA’s interpretation and held that orphan drug exclusivity extends to all uses or indications for the disease or condition.)

Passed Dec 2, 2025 1 co-sponsor
Co-sponsor HR 6324
In committee · United States House · Co-sponsor
Retirement Simplification and Clarity Act

Maddy summaryThis bill allows workers aged 50 or older to directly roll over employer retirement contributions (from 401(k) plans) into an individual retirement annuity without triggering immediate taxes or penalties. It requires retirement plan administrators to provide clear, plain-language written explanations about rollover rules, including a 30-day review period, tax implications (like the 10% early withdrawal penalty), and what types of distributions cannot be rolled over (such as required minimum distributions). The rules apply to taxable years starting after December 31, 2025, and aim to simplify the process for older workers changing jobs or managing retirement funds. It directly affects workers aged 50+ and retirement plan administrators who must comply with the new disclosure standards.

In committee Nov 28, 2025 1 co-sponsor
Co-sponsor HR 6280
In committee · United States House · Co-sponsor
Access to Genetic Counselor Services Act of 2025

Maddy summaryThis bill expands Medicare coverage to include genetic counseling services provided by licensed or certified genetic counselors, effective January 1, 2027. It defines "covered genetic counseling services" as those furnished by qualified counselors under state law or certification, with payments set at 80% of the lesser of the actual charge or 85% of the physician fee schedule. Medicare beneficiaries seeking genetic counseling will gain access to these services through covered providers, while preventing balance billing for these specific services. The bill does not restrict physicians from billing for similar services under existing Medicare rules.

In committee Nov 21, 2025 1 co-sponsor
Co-sponsor HR 6170
In committee · United States House · Co-sponsor
ADOPT Act of 2025

Maddy summaryThe ADOPT Act of 2025 creates federal offenses to prevent exploitation in private domestic interstate adoptions. It prohibits unlicensed groups from acting as intermediaries between birth parents and adoptive parents, restricts certain adoption advertising, and caps payments to birth parents at $2,500 before consulting a licensed agency or attorney. The bill directly affects unlicensed adoption facilitators, birth parents, and prospective adoptive parents by requiring all adoption services to occur through licensed providers or exempt entities like attorneys and nonprofit agencies. Violations carry fines up to $100,000 for organizations or $50,000 plus 5 years in prison for individuals, with exemptions for public agencies, licensed child-placing organizations, and attorneys.

In committee Nov 20, 2025 1 co-sponsor
Co-sponsor HR 6214
In committee · United States House · Co-sponsor
Kidney Care Access Protection Act

Maddy summaryThe Kidney Care Access Protection Act (HR 6214) improves access to innovative kidney treatments for Medicare beneficiaries with end-stage renal disease. It extends transitional payment adjustments for new renal dialysis drugs and devices for at least three years, then establishes permanent payment adjustments based on actual utilization and costs. The bill also expands Medicare's annual wellness benefit to include kidney disease screening and increases access to kidney disease education services through renal dialysis facilities. These changes apply to Medicare beneficiaries, renal dialysis facilities, and healthcare providers, with key provisions effective January 1, 2026.

In committee Nov 20, 2025 1 co-sponsor
Co-sponsor HR 6219
In committee · United States House · Co-sponsor
Conscience Protections for Medical Residents Act

Maddy summaryThis bill prohibits Medicare-approved medical residency programs from requiring residents to undergo abortion training without their voluntary consent. It specifically bans programs from making such training mandatory (requiring residents to "opt-in" rather than "opt-out") or from discriminating against residents who refuse this training or do not perform abortions. The law directly affects medical residents in Medicare-funded postgraduate training programs across the U.S., ensuring they cannot be forced into abortion-related clinical experiences or penalized for declining them.

In committee Nov 20, 2025 1 co-sponsor
Showing 91 to 100 of 1,026 bills
Previous 1 … 9 10 11 … 103 Next